Disc Medicine, Inc. (IRON) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Watertown, MA, 미국. 현재 CEO는 John D. Quisel.
IRON 을(를) 보유 IPO 날짜 2020-08-12, 94 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $2.69B.
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
